IRSIX
Price
$13.64
Change
-$0.00 (-0.00%)
Updated
Jul 16 closing price
Net Assets
399.9M
VSCIX
Price
$141.94
Change
-$0.78 (-0.55%)
Updated
Jul 17 closing price
Net Assets
188.57B
Interact to see
Advertisement

IRSIX vs VSCIX

IRSIX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
IRSIX vs. VSCIX commentary
Jul 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRSIX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. IRSIX (400M). VSCIX pays higher dividends than IRSIX: VSCIX (1.20) vs IRSIX (0.95). IRSIX was incepted earlier than VSCIX: IRSIX (18 years) vs VSCIX (29 years). IRSIX (1.11) is less costly to investors than VSCIX (0.03). VSCIX is a more actively managed with annual turnover of: 17.00 vs. IRSIX (11.00). IRSIX has a lower initial minimum investment than VSCIX: IRSIX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.03 vs. IRSIX (16.75). VSCIX return over 5 years is better than : 39.98 vs. IRSIX (-12.21).
IRSIXVSCIXIRSIX / VSCIX
Total Expense Ratio0.930.033,100%
Annual Report Gross Expense Ratio1.110.033,700%
Fund Existence18 years29 years-
Gain YTD5.65215.04538%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets400M189B0%
Annual Yield % from dividends0.951.2079%
Returns for 1 year16.7522.0376%
Returns for 3 years10.1944.9423%
Returns for 5 years-12.2139.98-31%
Returns for 10 years15.74157.0010%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZKIN1.390.04
+2.96%
ZK International Group Co Ltd
CHKP137.100.59
+0.43%
Check Point Software Technologies Ltd
OSW26.41-0.22
-0.83%
OneSpaWorld Holdings Limited
MSS0.56-0.01
-0.98%
Maison Solutions Inc.
CBIO14.75-0.36
-2.38%
Crescent Biopharma Inc